Cargando…

Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function

BACKGROUND: It has long been recognized that vitamin D deficiency is associated with muscle weakness and falls. Vitamin D receptor (VDR) is present at very low levels in normal muscle. Whether vitamin D plays a direct role in muscle function is unknown and is a subject of hot debate. Myocyte‐specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Girgis, Christian M., Cha, Kuan Minn, So, Benjamin, Tsang, Michael, Chen, Jennifer, Houweling, Peter J., Schindeler, Aaron, Stokes, Rebecca, Swarbrick, Michael M., Evesson, Frances J., Cooper, Sandra T., Gunton, Jenny E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903451/
https://www.ncbi.nlm.nih.gov/pubmed/31225722
http://dx.doi.org/10.1002/jcsm.12460
_version_ 1783477851125710848
author Girgis, Christian M.
Cha, Kuan Minn
So, Benjamin
Tsang, Michael
Chen, Jennifer
Houweling, Peter J.
Schindeler, Aaron
Stokes, Rebecca
Swarbrick, Michael M.
Evesson, Frances J.
Cooper, Sandra T.
Gunton, Jenny E.
author_facet Girgis, Christian M.
Cha, Kuan Minn
So, Benjamin
Tsang, Michael
Chen, Jennifer
Houweling, Peter J.
Schindeler, Aaron
Stokes, Rebecca
Swarbrick, Michael M.
Evesson, Frances J.
Cooper, Sandra T.
Gunton, Jenny E.
author_sort Girgis, Christian M.
collection PubMed
description BACKGROUND: It has long been recognized that vitamin D deficiency is associated with muscle weakness and falls. Vitamin D receptor (VDR) is present at very low levels in normal muscle. Whether vitamin D plays a direct role in muscle function is unknown and is a subject of hot debate. Myocyte‐specific deletion of VDR would provide a strategy to answer this question. METHODS: Myocyte‐specific vitamin D receptor (mVDR) null mice were generated by crossing human skeletal actin‐Cre mice with floxed VDR mice. The effects of gene deletion on the muscle phenotype were studied in terms of body tissue composition, muscle tissue histology, and gene expression by real‐time PCR. RESULTS: Unlike whole‐body VDR knockout mice, mVDR mice showed a normal body size. The mVDR showed a distinct muscle phenotype featuring reduced proportional lean mass (70% vs. 78% of lean mass), reduced voluntary wheel‐running distance (22% decrease, P = 0.009), reduced average running speed, and reduced grip strength (7–16% reduction depending on age at testing). With their decreased voluntary exercise, and decreased lean mass, mVDR have increased proportional fat mass at 20% compared with 13%. Surprisingly, their muscle fibres showed slightly increased diameter, as well as the presence of angular fibres and central nuclei suggesting ongoing remodelling. There were, however, no clear changes in fibre type and there was no increase in muscle fibrosis. VDR is a transcriptional regulator, and changes in the expression of candidate genes was examined in RNA extracted from skeletal muscle. Alterations were seen in myogenic gene expression, and there was decreased expression of cell cycle genes cyclin D1, D2, and D3 and cyclin‐dependent kinases Cdk‐2 and Cdk‐4. Expression of calcium handling genes sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) Serca2b and Serca3 was decreased and Calbindin mRNA was lower in mVDR muscle. CONCLUSIONS: This study demonstrates that vitamin D signalling is needed for myocyte function. Despite the low level of VDR protein normally found muscle, deleting myocyte VDR had important effects on muscle size and strength. Maintenance of normal vitamin D signalling is a useful strategy to prevent loss of muscle function and size.
format Online
Article
Text
id pubmed-6903451
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69034512019-12-19 Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function Girgis, Christian M. Cha, Kuan Minn So, Benjamin Tsang, Michael Chen, Jennifer Houweling, Peter J. Schindeler, Aaron Stokes, Rebecca Swarbrick, Michael M. Evesson, Frances J. Cooper, Sandra T. Gunton, Jenny E. J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: It has long been recognized that vitamin D deficiency is associated with muscle weakness and falls. Vitamin D receptor (VDR) is present at very low levels in normal muscle. Whether vitamin D plays a direct role in muscle function is unknown and is a subject of hot debate. Myocyte‐specific deletion of VDR would provide a strategy to answer this question. METHODS: Myocyte‐specific vitamin D receptor (mVDR) null mice were generated by crossing human skeletal actin‐Cre mice with floxed VDR mice. The effects of gene deletion on the muscle phenotype were studied in terms of body tissue composition, muscle tissue histology, and gene expression by real‐time PCR. RESULTS: Unlike whole‐body VDR knockout mice, mVDR mice showed a normal body size. The mVDR showed a distinct muscle phenotype featuring reduced proportional lean mass (70% vs. 78% of lean mass), reduced voluntary wheel‐running distance (22% decrease, P = 0.009), reduced average running speed, and reduced grip strength (7–16% reduction depending on age at testing). With their decreased voluntary exercise, and decreased lean mass, mVDR have increased proportional fat mass at 20% compared with 13%. Surprisingly, their muscle fibres showed slightly increased diameter, as well as the presence of angular fibres and central nuclei suggesting ongoing remodelling. There were, however, no clear changes in fibre type and there was no increase in muscle fibrosis. VDR is a transcriptional regulator, and changes in the expression of candidate genes was examined in RNA extracted from skeletal muscle. Alterations were seen in myogenic gene expression, and there was decreased expression of cell cycle genes cyclin D1, D2, and D3 and cyclin‐dependent kinases Cdk‐2 and Cdk‐4. Expression of calcium handling genes sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) Serca2b and Serca3 was decreased and Calbindin mRNA was lower in mVDR muscle. CONCLUSIONS: This study demonstrates that vitamin D signalling is needed for myocyte function. Despite the low level of VDR protein normally found muscle, deleting myocyte VDR had important effects on muscle size and strength. Maintenance of normal vitamin D signalling is a useful strategy to prevent loss of muscle function and size. John Wiley and Sons Inc. 2019-06-21 2019-12 /pmc/articles/PMC6903451/ /pubmed/31225722 http://dx.doi.org/10.1002/jcsm.12460 Text en © 2019 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Girgis, Christian M.
Cha, Kuan Minn
So, Benjamin
Tsang, Michael
Chen, Jennifer
Houweling, Peter J.
Schindeler, Aaron
Stokes, Rebecca
Swarbrick, Michael M.
Evesson, Frances J.
Cooper, Sandra T.
Gunton, Jenny E.
Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function
title Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function
title_full Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function
title_fullStr Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function
title_full_unstemmed Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function
title_short Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function
title_sort mice with myocyte deletion of vitamin d receptor have sarcopenia and impaired muscle function
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903451/
https://www.ncbi.nlm.nih.gov/pubmed/31225722
http://dx.doi.org/10.1002/jcsm.12460
work_keys_str_mv AT girgischristianm micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT chakuanminn micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT sobenjamin micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT tsangmichael micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT chenjennifer micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT houwelingpeterj micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT schindeleraaron micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT stokesrebecca micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT swarbrickmichaelm micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT evessonfrancesj micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT coopersandrat micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction
AT guntonjennye micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction